Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Organisation
Files
Mentors
Basic
Bibliography
Published theses
Top keywords
Keyword timeline
Co-mentors
Bibliography of the person, including all types of documents, not only theses.
MSc theses (1)
Neža Omersa:
Razvoj metod za in vitro proučevanje tkivnozaščitnih učinkov eritropoetina v celičnem modelu
BSc theses (3)
Nika Veber:
Vpliv polimorfizma c.2846A>G v genu MSH3 na tveganje za razvoj raka na požiralniku v južnoafriški populaciji
Nina Kočevar Britovšek:
Preiskava proteoma z dvodimenzionalno gelsko elektroforezo pri raku želodca: optimizacija postopka in preliminarni poskusi
Marko Narobe:
Poskus obogatitve proteinov plazemske membrane iz želodčnega tkiva ter računalniško iskanje možnih bioloških označevalcev raka želodca
Other documents (12)
Marko Vidak, Ivana Jovchevska, Neja Šamec, Alja Zottel, Mirjana Liović, Damjana Rozman, Sašo Džeroski, Peter Juvan, Radovan Komel:
Meta-analysis and experimental validation identified FREM2 and SPRY1 as new glioblastoma marker candidates
Martin Sill, Christoph Schröder, Ying Shen, Aseel Marzoq, Radovan Komel, Jörg Hoheisel, Henrik Nienhüser, Thomas Schmidt, Damjana Kastelic:
Protein profiling gastric cancer and neighboring control tissues using high-content antibody microarrays
Ivana Jovchevska, Alja Zottel, Neja Šamec, Jernej Mlakar, Maxim Sorokin, Daniil Nikitin, Anton A. Buzdin, Radovan Komel:
High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomas
Marina Dermastia, Radovan Komel, Tom Turk:
Kjer se življenje začne ---
Patrícia Kimáková, Peter Solár, Zuzana Solárová, Radovan Komel, Nataša Debeljak:
Erythropoietin and its angiogenic activity
Alja Zottel, Ivana Jovchevska, Neja Šamec, Jernej Mlakar, Jernej Šribar, Igor Križaj, Marija Skoblar Vidmar, Radovan Komel:
Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
Špela Peternel, Radovan Komel:
Active protein aggregates produced in Escherichia coli
Marko Vidak, Damjana Rozman, Radovan Komel:
Effects of flavonoids from food and dietary supplements on glial and glioblastoma multiforme cells
Alja Zottel, Neja Šamec, Ana Kump, Lucija Raspor Dall'Olio, Pia Pužar Dominkuš, Rok Romih, Samo Hudoklin, Jernej Mlakar, Daniil Nikitin, Maxim Sorokin, Anton A. Buzdin, Ivana Jovchevska, Radovan Komel:
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in glioblastoma cell lines and extracellular vesicles
Alja Zottel, Ivana Jovchevska, Neja Šamec, Radovan Komel:
Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy
Andrej Porčnik, Metka Novak, Barbara Breznik, Bernarda Majc, Barbara Hrastar, Neja Šamec, Alja Zottel, Ivana Jovchevska, Miloš Vittori, Ana Rotter, Radovan Komel, Tamara Lah Turnšek:
TRIM28 selective nanobody reduces glioblastoma stem cell invasion
Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik, Ivana Jovchevska:
Anti-vimentin nanobody decreases glioblastoma cell invasion in vitro and in vivo